Bogsch will remain chairman of the board and will also assume the newly created position of Executive Chairman, focusing on commercial activities as well as international, public and government relations for the company, state news agency MTI reported.
The challenge for Richterʼs management, in the boardʼs assessment, is “to counter the headwinds in the highly competitive generic and branded markets by building an innovative product portfolio and thereby sustaining the company’s growth record.”
To meet this challenge, two “distinct but equally important” management tasks must be carried out at the same time, Richter said.
The first is “to efficiently operate the supply chain in traditional markets while remaining competitive in the fields of R&D, manufacturing, quality assurance and logistics, in the face of price erosion generated by both authorities and competitors, having at the same time to deal with cost pressures from various sources.”
The second is “to continue implementing the specialty pharma strategy by strengthening the recently established international sales network in Western Europe and overseas, while continuously broadening the high added-value innovative product portfolio,” the board added.
Producing journalism that is worthy of the name is a costly business. For over 30 years, the publishers, editors and reporters of the Budapest Business Journal have striven to bring you business news that works, information that you can trust, that is factual, accurate and presented without fear or favor.Newspaper organizations across the globe have struggled to find a business model that allows them to continue to excel, without compromising their ability to perform. Most recently, some have experimented with the idea of involving their most important stakeholders, their readers.
We would like to offer that same opportunity to our readers. We would like to invite you to help us deliver the quality business journalism you require. Hit our Support the BBJ button and you can choose the how much and how often you send us your contributions.
